scispace - formally typeset
V

Victoria El-Khoury

Researcher at University of Luxembourg

Publications -  15
Citations -  5749

Victoria El-Khoury is an academic researcher from University of Luxembourg. The author has contributed to research in topics: Apoptosis & Autophagy. The author has an hindex of 9, co-authored 12 publications receiving 5226 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material

TL;DR: Compared the efficiency of commonly used RNA extraction kits in miRNA recovery from cells, plasma and urine/plasma-derived exosomes, using single-gene RT-qPCR and miRNA profiling, it is shown that miRNAs were preferentially or exclusively isolated by either of the methods.
Journal ArticleDOI

Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer

TL;DR: This review presents an analysis of the role of cfDNA as a liquid biopsy technique and NGS as an analytical tool in studying EGFR and MET, two frequently mutated genes in lung cancer.
Journal Article

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2459 more
- 01 Jan 2016 - 
Journal ArticleDOI

Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia.

TL;DR: It is shown that MGCD0103 decreases the autophagic flux in primary CLL cells, and it is demonstrated that autophagy is a pro-survival mechanism in CLL whose disruption potentiates cell death induced by anticancer molecules including HDAC and cyclin-dependent kinase inhibitors.